HC Wainwright reissued their buy rating on shares of Vir Biotechnology (NASDAQ:VIR – Free Report) in a research note published on Friday, Benzinga reports. They currently have a $110.00 price objective on the stock. A number of other research firms have also weighed in on VIR. JPMorgan Chase & Co. boosted their target price on […]
Vir Biotechnology's (VIR) "Buy" Rating Reaffirmed at HC Wainwright theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Vir Biotechnology's (VIR) "Buy" Rating Reaffirmed at HC Wainwright themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Vir Biotechnology, Inc. (NASDAQ:VIR) Given Consensus Recommendation of "Moderate Buy" by Analysts wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.
Vir Biotechnology, Inc. (NASDAQ:VIR) Receives Average Rating of "Moderate Buy" from Brokerages tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.